Predictors of short-term mortality after rheumatic heart valve surgery: A single-center retrospective study
- PMID: 33552502
- PMCID: PMC7851328
- DOI: 10.1016/j.amsu.2021.01.077
Predictors of short-term mortality after rheumatic heart valve surgery: A single-center retrospective study
Abstract
Background: Valve replacement surgeries holds risks of morbidity and mortality.
Materials and methods: The study cohort included 346 patients who underwent different types of valve surgery, excluding redo and Bentall operations. All operations were performed through a median sternotomy using cardiopulmonary bypass.
Results: Mean patient age was 51.6 ± 16.1 years, and 51% were male. Approximately 21% had diabetes, and 44.6% were hypertensive. Aortic valve replacement (AVR) was performed in 125 patients (37%), mitral valve replacement (MVR) in 95 (28%), combined AVR and MVR in 42 (13%), AVR plus coronary artery bypass grafting (CABG) in 19 (6%), and MVR plus CABG in 32 (10%). Operative mortality was 5.8% (n = 20). In the bivariate-level analysis, older age, operation type, hypertension, emergency surgery, use of a biological valve in the aortic or mitral position, pump time greater than 120 min, and aortic clamp time greater than 60 min were significant predictors of 30-day mortality. Use of medications stratified by duration (less than or more than a month) was also shown to be a predictor of mortality. Use of angiotensin-converting enzyme inhibitors, digoxin, beta-blockers, statins, and loop diuretics was associated with mortality. Older age, emergency/salvage surgery, use of beta-blockers for less than 1 month preoperatively, and use of a biological valve in the aortic position were significant and independent predictors of 30-day mortality.
Conclusion: Age, emergency valve surgery, use of a biological valve, use of beta-blockers for less than 1 month before surgery, type of surgery, EF<35%, pump time, and cross clamp time were all found to be independent predictors of mortality in patients undergoing valve surgery. Further prospective multicenter studies may be needed to provide a comprehensive assessment of mortality in patients undergoing valve surgery in Jordan.
Keywords: Emergency surgery; Mortality; Predictors; Valve surgery.
© 2021 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
Conflict of interest statement
NO CONFLICT OF INTEREST OF ANY TYPE FOR ANY OF THE AUTHORS.
References
-
- Enriquez-Sarano M., Schaff H.V., Orszulak T.A., Tajik A.J., Bailey K.R., Frye R.L. Valve repair improves the outcome of surgery for mitral regurgitation. A multivariate analysis. Circulation. 1995;91(4):1022–1028. - PubMed
-
- Nowicki E.R., Birkmeyer N.J., Weintraub R.W., Leavitt B.J., Sanders J.H., Dacey L.J. Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann. Thorac. Surg. 2004;77(6):1966–1977. - PubMed
-
- Taylor N.E., O'Brien S., Edwards F.H., Peterson E.D., Bridges C.R. Relationship between race and mortality and morbidity after valve replacement surgery. Circulation. 2005;111(10):1305–1312. - PubMed
-
- AlWaqfi N., Khader Y., Ibrahim K. Coronary artery bypass: predictors of 30-day operative mortality in Jordanians. Asian Cardiovasc. Thorac. Ann. 2012;20(3):245–251. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
